Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.30
Delayed Data
As of 3:59pm ET
 +0.08 / +2.48%
Today’s Change
2.85
Today|||52-Week Range
5.13
-6.78%
Year-to-Date
Meditor Group Ltd Buys Celldex Therapeutics, Sells VIVUS
Apr 24 / GuruFocus News - Paid Partner Content
What's in Store for Biogen (BIIB) this Earnings Season?
Apr 20 / Zacks.com - Paid Partner Content
What's in Store for GlaxoSmithKline (GSK) in Q1 Earnings?
Apr 21 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards?
Apr 20 / Zacks.com - Paid Partner Content
Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again?
Apr 21 / Zacks.com - Paid Partner Content
Why Is Celldex (CLDX) Down 4.4% Since the Last Earnings Report?
Apr 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close3.22
Today’s open3.22
Day’s range3.21 - 3.33
Volume1,438,776
Average volume (3 months)1,847,326
Market cap$396.7M
Dividend yield--
Data as of 3:59pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)+3.05%
Earnings growth (this year)+5.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+23.83%
P/E ratioNM
Price/Sales52.96
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...+0.60+5.41%
LNTHLantheus Holdings In...0.000.00%
OXFDOxford Immunotec Glo...-0.06-0.39%
VCYTVeracyte Inc+0.44+5.66%
Data as of 3:59pm ET, 04/25/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$6.8M
Annual profit (last year)-$128.5M
Net profit margin-1,894.05%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts


Search for Jobs